David Beffa, MD
Surgery · Sacramento, CANPI 1184821977
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $92,585 of the $130,931 with a category attached, or 70.7%. Intuitive Surgical accounts for 95.6% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2022 at $59,114 and has fallen 99.3% since, to $431 in 2025. Among surgery clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 270 payments — averaging $484.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$125K
- AbbVie$5K
- Johnson & Johnson$291
- Boston Scientific$212
- Acell, Inc.$184
- Integra Lifesciences Corporation$168
- plus $317 from 5 others
What the payments were for
- Speaking & faculty fees$92,58571%
- Travel & lodging$14,40811%
- Food & beverage$7,8986%
- Education$16,04012%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 197 | $125,220 |
| AbbVie(2 entities) | 51 | $4,539 |
| Johnson & Johnson | 4 | $291 |
| Boston Scientific | 2 | $212 |
| Acell, Inc. | 3 | $184 |
| Integra Lifesciences Corporation | 7 | $168 |
| Aroa Biosurgery Incorporated | 2 | $140 |
| Teleflex LLC | 1 | $65 |
| Conmed Corporation | 1 | $63 |
| KCI USA, Inc. | 1 | $27 |
| Lexington Medical, Inc. | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$107,219
- DA VINCI SP$15,300
- AVYCAZ$2,218
- DALVANCE$1,164
- SPYGLASS$137
- Echelon Circular$115
How this compares
$130,931 in reported general payments places this provider in the 95th percentile of 2,363 surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 17 | $421 |
| Ondansetron OdtOndansetron | 54 | $275 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 76 | $205 |
| Ketorolac Tromethamine | 23 | $192 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 29 | $178 |
| Azithromycin | 59 | $177 |
| Methylprednisolone | 18 | $111 |
| Prednisone | 42 | $104 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 13 | $93 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 33 | $79 |
| Cephalexin | 11 | $57 |
| Ciprofloxacin Hcl | 18 | $51 |
| Tamsulosin Hcl | 12 | $45 |
| Lisinopril | 13 | $25 |
Paid to pharmacies, not to this prescriber.
Other surgery in Sacramento
- Michael BenekeSacramento$234K
- Timothy ChuterSan Francisco$8.8M
- Santiago HorganSan Diego$2.8M
- Rock LiuHayward$1.6M
- David LouriePasadena$1.4M
- Andrea PakulaThousand Oaks$1.4M
- Siew-Ming LeeFresno$1.3M
- Beemen KhalilPalo Alto$1.1M
- John LiphamLos Angeles$942K
- Alexander NedopilLodi$682K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.